Literature DB >> 12679864

Functional differences between human formyl peptide receptor isoforms 26, 98, and G6.

Katharina Wenzel-Seifert1, Roland Seifert.   

Abstract

The formyl peptide receptor (FPR) is expressed in neutrophils, couples to G(i)-proteins and activates phospholipase C, chemotaxis and cytotoxic cell functions. FPR isoforms 26, 98, and G6 differ from each other in amino acids 101, 192 and 346 (FPR-26: V101, N192, E346; FPR-98: L101, N192, A346; FPR-G6: V101, K192, A346), but the functional significance of those structural differences is unknown. In order to address this question, we analyzed FPR-26, FPR-98 and FPR-G6 by co-expressing recombinant FLAG epitope-tagged FPRs with the G-protein G(i)alpha(2)beta(1)gamma(2) in Sf9 insect cells and measured high-affinity agonist binding and guanosine 5'- O-(3-thiotriphosphate) (GTPgammaS) binding. The B(max) values of high-affinity agonist binding with FPR-98 and FPR-G6 were much lower than with FPR-26. FPR-98 and FPR-G6 activated considerably fewer G(i)-proteins, and were much less constitutively active, than FPR-26. Whereas FPR-26 migrated as a monomer in SDS polyacrylamide electrophoresis, FPR-98 and FPR-G6 migrated as dimers and tetramers. In terms of immunoreactivity, FRP-98 and FPR-G6 were expressed at higher levels than FPR-26. Single amino acid exchanges at positions 101 (V-->L), 192 (N-->K) and 346 (E-->A) in FPR-26 revealed that E346 accounts for FPR-26 migrating as a monomer and the high constitutive activity of FPR-26. The V101L, N192K and E346A exchanges all reduced high-affinity agonist binding and the number of G(i)-proteins activated by FPR-26. We conclude that (i) FPR isoforms 98 and G6 exhibit a partial G(i)-protein coupling defect relative to FPR-26 and that (ii) E346 critically determines constitutive activity, G(i)-protein coupling and physical state of FPR-26.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12679864     DOI: 10.1007/s00210-003-0714-7

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  26 in total

1.  Absence of G(i) proteins in the Sf9 insect cell. Characterization of the uncoupled recombinant N-formyl peptide receptor.

Authors:  O Quehenberger; E R Prossnitz; C G Cochrane; R D Ye
Journal:  J Biol Chem       Date:  1992-10-05       Impact factor: 5.157

Review 2.  The superoxide-forming NADPH oxidase of phagocytes. An enzyme system regulated by multiple mechanisms.

Authors:  R Seifert; G Schultz
Journal:  Rev Physiol Biochem Pharmacol       Date:  1991       Impact factor: 5.545

3.  Signal amplification in HL-60 granulocytes. Evidence that the chemotactic peptide receptor catalytically activates guanine-nucleotide-binding regulatory proteins in native plasma membranes.

Authors:  P Gierschik; R Moghtader; C Straub; K Dieterich; K H Jakobs
Journal:  Eur J Biochem       Date:  1991-05-08

4.  Sequence and organization of the human N-formyl peptide receptor-encoding gene.

Authors:  P M Murphy; H L Tiffany; D McDermott; S K Ahuja
Journal:  Gene       Date:  1993-11-15       Impact factor: 3.688

Review 5.  The molecular biology of leukocyte chemoattractant receptors.

Authors:  P M Murphy
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

6.  Constitutive activity of human prostaglandin E receptor EP3 isoforms.

Authors:  J Jin; G F Mao; B Ashby
Journal:  Br J Pharmacol       Date:  1997-05       Impact factor: 8.739

7.  Dual Mg2+ control of formyl-peptide-receptor--G-protein interaction in HL 60 cells. Evidence that the low-agonist-affinity receptor interacts with and activates the G-protein.

Authors:  P Gierschik; M Steisslinger; D Sidiropoulos; E Herrmann; K H Jakobs
Journal:  Eur J Biochem       Date:  1989-07-15

8.  High constitutive activity of the human formyl peptide receptor.

Authors:  K Wenzel-Seifert; C M Hurt; R Seifert
Journal:  J Biol Chem       Date:  1998-09-11       Impact factor: 5.157

9.  Regulation of the superoxide-forming NADPH oxidase of human neutrophils is not altered in essential hypertension.

Authors:  R Seifert; G Hilgenstock; M Fassbender; A Distler
Journal:  J Hypertens       Date:  1991-02       Impact factor: 4.844

10.  Cyclosporin H is a potent and selective formyl peptide receptor antagonist. Comparison with N-t-butoxycarbonyl-L-phenylalanyl-L-leucyl-L-phenylalanyl-L- leucyl-L-phenylalanine and cyclosporins A, B, C, D, and E.

Authors:  K Wenzel-Seifert; R Seifert
Journal:  J Immunol       Date:  1993-05-15       Impact factor: 5.422

View more
  7 in total

1.  Polymorphism of formyl peptide receptor 1 (FPR1) reduces the therapeutic efficiency and antitumor immunity after neoadjuvant chemoradiotherapy (CCRT) treatment in locally advanced rectal cancer.

Authors:  Tao-Wei Ke; Shu-Fen Chiang; Kevin Chih-Yang Huang; William Tzu-Liang Chen; Tsung-Wei Chen; K S Clifford Chao
Journal:  Cancer Immunol Immunother       Date:  2021-03-13       Impact factor: 6.968

2.  The leukocyte chemotactic receptor FPR1 is functionally expressed on human lens epithelial cells.

Authors:  Erich H Schneider; Joseph D Weaver; Sonia S Gaur; Brajendra K Tripathi; Algirdas J Jesaitis; Peggy S Zelenka; Ji-Liang Gao; Philip M Murphy
Journal:  J Biol Chem       Date:  2012-09-25       Impact factor: 5.157

3.  Formylpeptide receptor single nucleotide polymorphism 348T>C and its relationship to polymorphonuclear leukocyte chemotaxis in aggressive periodontitis.

Authors:  Pooja Maney; John D Walters
Journal:  J Periodontol       Date:  2009-09       Impact factor: 6.993

Review 4.  The role of formylated peptides and formyl peptide receptor 1 in governing neutrophil function during acute inflammation.

Authors:  David A Dorward; Christopher D Lucas; Gavin B Chapman; Christopher Haslett; Kevin Dhaliwal; Adriano G Rossi
Journal:  Am J Pathol       Date:  2015-03-17       Impact factor: 4.307

5.  An independent predictor of poor prognosis in locally advanced rectal cancer: rs867228 in formyl peptide receptor 1 (FPR1).

Authors:  Shu-Fen Chiang; Kevin Chih-Yang Huang; William Tzu-Liang Chen; Tsung-Wei Chen; Tao-Wei Ke; K S Clifford Chao
Journal:  Oncoimmunology       Date:  2021-05-14       Impact factor: 8.110

6.  Full characterization of GPCR monomer-dimer dynamic equilibrium by single molecule imaging.

Authors:  Rinshi S Kasai; Kenichi G N Suzuki; Eric R Prossnitz; Ikuko Koyama-Honda; Chieko Nakada; Takahiro K Fujiwara; Akihiro Kusumi
Journal:  J Cell Biol       Date:  2011-02-07       Impact factor: 10.539

Review 7.  The N-formyl peptide receptors and the anaphylatoxin C5a receptors: an overview.

Authors:  Marie-Josèphe Rabiet; Emilie Huet; François Boulay
Journal:  Biochimie       Date:  2007-03-03       Impact factor: 4.079

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.